Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly.
| Autor: | Baha, Ayşe, Köktürk, Nurdan, Baysan, Caner, Öztürk, Burcu, Cengiz, Sümeyye Kodalak, Varol, Yelda, Mertoğlu, Aydan, Çırak, Ali Kadri, Turan, Onur, Dursunoğlu, Neşe, Savurmuş, Nilufer, Gürgün, Alev, Elmas, Funda, Çöplü, Lütfi, Sertçelik, Ümran, Yıldız, Reyhan, Özmen, İpek, Alpaydın, Aylin Özgen |
|---|---|
| Předmět: |
MEDICAL rehabilitation
RESEARCH STATISTICS SCIENTIFIC observation CONFIDENCE intervals NUTRITION LUNG diseases PATIENT selection MULTIVARIATE analysis MANN Whitney U Test REGRESSION analysis COMPARATIVE studies OBSTRUCTIVE lung diseases HOSPITAL care COST analysis SOCIAL status CHI-squared test SOCIAL classes DESCRIPTIVE statistics SMOKING DATA analysis software LOGISTIC regression analysis BODY mass index ODDS ratio DISEASE exacerbation ANTIBIOTICS LONGITUDINAL method COMORBIDITY |
| Zdroj: | Thoracic Research & Practice; Jan2024, Vol. 25 Issue 1, p17-25, 9p |
| Abstrakt: | OBJECTIVE: Chronic obstructive pulmonary disease (COPD) that is the third leading cause of death in the world is one of the main economic burden. The cost is primarily due to COPD exacerbations and hospitalizations. We aimed to determine the factors associated with increasing costs in severe COPD exacerbation. MATERIAL AND METHODS: It was a multicenter and prospective observational recording study. 294 patients who severe COPD exacerbation were included in the study. An amount of more than 429.58 euros was accepted as increasing costs (IC). Factors associated with IC were determined by regression analysis. RESULTS: Mean age was 69.90 ± 9.79/years (minimum: 40 maximum: 95), mean costs were 594.9 ± 70.9 euros. About 83.7% of the patients were male, 24.1% (71) were active smokers, and 81% (238) had at least 1 comorbidity. Factors associated with IC in the regression analysis were delay of discharge (due to prolonged consultation), antibiotic use longer than 7 days, need to enteral/parenteral feeding, application of pulmonary rehabilitation (physiotherapy) at hospitalization, and refusal to be discharged. CONCLUSION: The increasing costs in severe COPD exacerbation depends not only treatment but also the patient's social status and hospital-related factors. We think that the cost of severe COPD exacerbation can be reduced by interventions on interchangeable factors such as patient's social status and hospital-related factors. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|